Cell-based approaches to joint surface repair: A research perspective

Osteoarthritis and Cartilage

Volumn 21, Issue 7, 2013, Pages 892-900

  Roelofs, A J ^a,b   Rocke, J P J ^a,b   De Bari, C ^a,b  

^a Arthritis Research UK Tissue Engineering Centre   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Cartilage; Cell therapy; Chondrocyte; Mesenchymal stem cell; Osteoarthritis

Indexed keywords

ARTICULAR CARTILAGE; AUTOGRAFT; AUTOLOGOUS CHONDROCYTE IMPLANTATION; BONE MARROW CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CELL THERAPY; CHONDROCYTE IMPLANTATION; ENCHONDRAL OSSIFICATION; FOLLOW UP; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOARTHRITIS; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SIGNAL TRANSDUCTION;

CARTILAGE, ARTICULAR; CHONDROCYTES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; ORTHOPEDIC PROCEDURES; OSTEOARTHRITIS; TISSUE SCAFFOLDS; TRANSPLANTATION, AUTOLOGOUS; WOUND HEALING;

EID: 84879464101     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.04.008     Document Type: Review

References (101)

1. Buckwalter J.A., Brown T.D. Joint injury, repair, and remodeling: roles in post-traumatic osteoarthritis. Clin Orthop Relat Res 2004, 423:7-16.
2. Gelber A.C., Hochberg M.C., Mead L.A., Wang N.Y., Wigley F.M., Klag M.J. Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann Intern Med 2000, 133(5):321-328.
3. Roberts S., Genever P., McCaskie A., De Bari C. Prospects of stem cell therapy in osteoarthritis. Regen Med 2011, 6(3):351-366.
4. Magnussen R.A., Dunn W.R., Carey J.L., Spindler K.P. Treatment of focal articular cartilage defects in the knee: a systematic review. Clin Orthop Relat Res 2008, 466(4):952-962.
5. Hangody L., Fules P. Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience. JBone Joint Surg Am 2003, 85-A(Suppl 2):25-32.
6. Frank R.M., Van Thiel G.S., Slabaugh M.A., Romeo A.A., Cole B.J., Verma N.N. Clinical outcomes after microfracture of the glenohumeral joint. Am J Sports Med 2010, 38(4):772-781.
7. Steadman J.R., Briggs K.K., Rodrigo J.J., Kocher M.S., Gill T.J., Rodkey W.G. Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. Arthroscopy 2003, 19(5):477-484.
8. Kreuz P.C., Steinwachs M.R., Erggelet C., Krause S.J., Konrad G., Uhl M., et al. Results after microfracture of full-thickness chondral defects in different compartments in the knee. Osteoarthritis Cartilage 2006, 14(11):1119-1125.
9. Minas T., Gomoll A.H., Rosenberger R., Royce R.O., Bryant T. Increased failure rate of autologous chondrocyte implantation after previous treatment with marrow stimulation techniques. Am J Sports Med 2009, 37(5):902-908.
10. Knutsen G., Drogset J.O., Engebretsen L., Grøntvedt T., Isaksen V., Ludvigsen T.C., et al. Arandomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. JBone Joint Surg Am 2007, 89(10):2105-2112.
11. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. NEngl J Med 1994, 331(14):889-895.
12. Kuroda T., Matsumoto T., Mifune Y., Fukui T., Kubo S., Matsushita T., et al. Therapeutic strategy of third-generation autologous chondrocyte implantation for osteoarthritis. Ups J Med Sci 2011, 116(2):107-114.
13. Jacobi M., Villa V., Magnussen R.A., Neyret P.M. MACI - a new era?. Sports Med Arthrosc Rehabil Ther Technol 2011, 3(1):10.
14. Bentley G., Biant L.C., Carrington R.W., Akmal M., Goldberg A., Williams A.M., et al. Aprospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. JBone Joint Surg Br 2003, 85(2):223-230.
15. Knutsen G., Engebretsen L., Ludvigsen T.C., Drogset J.O., Grontvedt T., Solheim E., et al. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. JBone Joint Surg Am 2004, 86-A(3):455-464.
16. Saris D.B., Vanlauwe J., Victor J., Haspl M., Bohnsack M., Fortems Y., et al. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med 2008, 36(2):235-246.
17. Vanlauwe J., Saris D.B., Victor J., Almqvist K.F., Bellemans J., Luyten F.P. Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: early treatment matters. Am J Sports Med 2011, 39(12):2566-2574.
18. Bentley G., Biant L.C., Vijayan S., Macmull S., Skinner J.A., Carrington R.W. Minimum ten-year results of a prospective randomised study of autologous chondrocyte implantation versus mosaicplasty for symptomatic articular cartilage lesions of the knee. JBone Joint Surg Br 2012, 94(4):504-509.
19. Peterson L., Vasiliadis H.S., Brittberg M., Lindahl A. Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med 2010, 38(6):1117-1124.
20. Barbero A., Grogan S., Schafer D., Heberer M., Mainil-Varlet P., Martin I. Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity. Osteoarthritis Cartilage 2004, 12(6):476-484.
21. Von der Mark K., Gauss V., Von der Mark H., Muller P. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature 1977, 267(5611):531-532.
22. Schnabel M., Marlovits S., Eckhoff G., Fichtel I., Gotzen L., Vecsei V., et al. Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis Cartilage 2002, 10(1):62-70.
23. Dell'Accio F., De Bari C., Luyten F.P. Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage invivo. Arthritis Rheum 2001, 44(7):1608-1619.
24. Roberts S., Hollander A.P., Caterson B., Menage J., Richardson J.B. Matrix turnover in human cartilage repair tissue in autologous chondrocyte implantation. Arthritis Rheum 2001, 44(11):2586-2598.
25. Saris D.B., Vanlauwe J., Victor J., Almqvist K.F., Verdonk R., Bellemans J., et al. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med 2009, 37(Suppl 1):10S-19S. TIG/ACT/01/2000&EXT Study Group.
26. Peterson L., Minas T., Brittberg M., Nilsson A., Sjogren-Jansson E., Lindahl A. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res 2000, 374:212-234.
27. Friedenstein A.J., Chailakhyan R.K., Latsinik N.V., Panasyuk A.F., Keiliss-Borok I.V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning invitro and retransplantation invivo. Transplantation 1974, 17(4):331-340.
28. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276(5309):71-74.
29. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284(5411):143-147.
30. Da Silva M.L., Chagastelles P.C., Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. JCell Sci 2006, 119(Pt 11):2204-2213.
31. Nakahara H., Bruder S.P., Goldberg V.M., Caplan A.I. Invivo osteochondrogenic potential of cultured cells derived from the periosteum. Clin Orthop Relat Res 1990, 259:223-232.
32. De Bari C., Dell'Accio F., Luyten F.P. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum 2001, 44(1):85-95.
33. De Bari C., Dell'Accio F., Vanlauwe J., Eyckmans J., Khan I.M., Archer C.W., et al. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 2006, 54(4):1209-1221.
34. De Bari C., Dell'Accio F., Tylzanowski P., Luyten F.P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001, 44(8):1928-1942.
35. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13(12):4279-4295.
36. Wakitani S., Goto T., Pineda S.J., Young R.G., Mansour J.M., Caplan A.I., et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. JBone Joint Surg Am 1994, 76(4):579-592.
37. Murphy J.M., Fink D.J., Hunziker E.B., Barry F.P. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003, 48(12):3464-3474.
38. Kuroda R., Ishida K., Matsumoto T., Akisue T., Fujioka H., Mizuno K., et al. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage 2007, 15(2):226-231.
39. Wakitani S., Nawata M., Tensho K., Okabe T., Machida H., Ohgushi H. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. JTissue Eng Regen Med 2007, 1(1):74-79.
40. Centeno C.J., Busse D., Kisiday J., Keohan C., Freeman M., Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician 2008, 11(3):343-353.
41. Wakitani S., Imoto K., Yamamoto T., Saito M., Murata N., Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 2002, 10(3):199-206.
42. Nejadnik H., Hui J.H., Feng Choong E.P., Tai B.C., Lee E.H. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med 2010, 38(6):1110-1116.
43. Sekiya I., Vuoristo J.T., Larson B.L., Prockop D.J. Invitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci USA 2002, 99(7):4397-4402.
44. Pelttari K., Winter A., Steck E., Goetzke K., Hennig T., Ochs B.G., et al. Premature induction of hypertrophy during invitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 2006, 54(10):3254-3266.
45. Scotti C., Tonnarelli B., Papadimitropoulos A., Scherberich A., Schaeren S., Schauerte A., et al. Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci USA 2010, 107(16):7251-7256.
46. Mauck R.L., Yuan X., Tuan R.S. Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture. Osteoarthritis Cartilage 2006, 14(2):179-189.
47. Huang A.H., Stein A., Tuan R.S., Mauck R.L. Transient exposure to transforming growth factor beta 3 improves the mechanical properties of mesenchymal stem cell-laden cartilage constructs in a density-dependent manner. Tissue Eng Part A 2009, 15(11):3461-3472.
48. Huang A.H., Stein A., Mauck R.L. Evaluation of the complex transcriptional topography of mesenchymal stem cell chondrogenesis for cartilage tissue engineering. Tissue Eng Part A 2010, 16(9):2699-2708.
49. De Bari C., Dell'Accio F., Luyten F.P. Failure of invitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage invivo. Arthritis Rheum 2004, 50(1):142-150.
50. Vinardell T., Sheehy E.J., Buckley C.T., Kelly D.J. Acomparison of the functionality and invivo phenotypic stability of cartilaginous tissues engineered from different stem cell sources. Tissue Eng Part A 2012, 18(11-12):1161-1170.
51. Farrell E., Both S.K., Odorfer K.I., Koevoet W., Kops N., O'Brien F.J., et al. In-vivo generation of bone via endochondral ossification by in-vitro chondrogenic priming of adult human and rat mesenchymal stem cells. BMC Musculoskelet Disord 2011, 12:31.
52. Qiu Y.S., Shahgaldi B.F., Revell W.J., Heatley F.W. Observations of subchondral plate advancement during osteochondral repair: a histomorphometric and mechanical study in the rabbit femoral condyle. Osteoarthritis Cartilage 2003, 11(11):810-820.
53. Cole B.J., Farr J., Winalski C.S., Hosea T., Richmond J., Mandelbaum B., et al. Outcomes after a single-stage procedure for cell-based cartilage repair: a prospective clinical safety trial with 2-year follow-up. Am J Sports Med 2011, 39(6):1170-1179.
54. Takahashi T., Tins B., McCall I.W., Richardson J.B., Takagi K., Ashton K. MR appearance of autologous chondrocyte implantation in the knee: correlation with the knee features and clinical outcome. Skeletal Radiol 2006, 35(1):16-26.
55. Kafienah W., Mistry S., Dickinson S.C., Sims T.J., Learmonth I., Hollander A.P. Three-dimensional cartilage tissue engineering using adult stem cells from osteoarthritis patients. Arthritis Rheum 2007, 56(1):177-187.
56. Kim Y.J., Kim H.J., Im G.I. PTHrP promotes chondrogenesis and suppresses hypertrophy from both bone marrow-derived and adipose tissue-derived MSCs. Biochem Biophys Res Commun 2008, 373(1):104-108.
57. Zhang W., Chen J., Zhang S., Ouyang H.W. Inhibitory function of parathyroid hormone-related protein on chondrocyte hypertrophy: the implication for articular cartilage repair. Arthritis Res Ther 2012, 14(4):221.
58. Studer D., Millan C., Ozturk E., Maniura-Weber K., Zenobi-Wong M. Molecular and biophysical mechanisms regulating hypertrophic differentiation in chondrocytes and mesenchymal stem cells. Eur Cell Mater 2012, 24:118-135.
59. Dowthwaite G.P., Bishop J.C., Redman S.N., Khan I.M., Rooney P., Evans D.J., et al. The surface of articular cartilage contains a progenitor cell population. JCell Sci 2004, 117(Pt 6):889-897.
60. Dell'Accio F., De Bari C., Luyten F.P. Microenvironment and phenotypic stability specify tissue formation by human articular cartilage-derived cells invivo. Exp Cell Res 2003, 287(1):16-27.
61. Williams R., Khan I.M., Richardson K., Nelson L., McCarthy H.E., Analbelsi T., et al. Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage. PLoS One 2010, 5(10):e13246.
62. Sakaguchi Y., Sekiya I., Yagishita K., Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005, 52(8):2521-2529.
63. Mochizuki T., Muneta T., Sakaguchi Y., Nimura A., Yokoyama A., Koga H., et al. Higher chondrogenic potential of fibrous synovium- and adipose synovium-derived cells compared with subcutaneous fat-derived cells: distinguishing properties of mesenchymal stem cells in humans. Arthritis Rheum 2006, 54(3):843-853.
64. Shirasawa S., Sekiya I., Sakaguchi Y., Yagishita K., Ichinose S., Muneta T. Invitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. JCell Biochem 2006, 97(1):84-97.
65. Yoshimura H., Muneta T., Nimura A., Yokoyama A., Koga H., Sekiya I. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res 2007, 327(3):449-462.
66. Koga H., Muneta T., Nagase T., Nimura A., Ju Y.J., Mochizuki T., et al. Comparison of mesenchymal tissues-derived stem cells for invivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit. Cell Tissue Res 2008, 333(2):207-215.
67. Alegre-Aguaron E., Desportes P., Garcia-Alvarez F., Castiella T., Larrad L., Martinez-Lorenzo M.J. Differences in surface marker expression and chondrogenic potential among various tissue-derived mesenchymal cells from elderly patients with osteoarthritis. Cells Tissues Organs 2012, 196(3):231-240.
68. Hennig T., Lorenz H., Thiel A., Goetzke K., Dickhut A., Geiger F., et al. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. JCell Physiol 2007, 211(3):682-691.
69. Marsano A., Millward-Sadler S.J., Salter D.M., Adesida A., Hardingham T., Tognana E., et al. Differential cartilaginous tissue formation by human synovial membrane, fat pad, meniscus cells and articular chondrocytes. Osteoarthritis Cartilage 2007, 15(1):48-58.
70. Mendez-Ferrer S., Michurina T.V., Ferraro F., Mazloom A.R., Macarthur B.D., Lira S.A., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466(7308):829-834.
71. Sacchetti B., Funari A., Michienzi S., Di Cesare S., Piersanti S., Saggio I., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131(2):324-336.
72. Park D., Spencer J.A., Koh B.I., Kobayashi T., Fujisaki J., Clemens T.L., et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell 2012, 10(3):259-272.
73. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8(4):315-317.
74. Muraglia A., Cancedda R., Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate invitro according to a hierarchical model. JCell Sci 2000, 113(Pt 7):1161-1166.
75. Karystinou A., Dell'Accio F., Kurth T.B., Wackerhage H., Khan I.M., Archer C.W., et al. Distinct mesenchymal progenitor cell subsets in the adult human synovium. Rheumatology (Oxford) 2009, 48(9):1057-1064.
76. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418(6893):41-49.
77. Jones E.A., Kinsey S.E., English A., Jones R.A., Straszynski L., Meredith D.M., et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002, 46(12):3349-3360.
78. Quirici N., Soligo D., Bossolasco P., Servida F., Lumini C., Deliliers G.L. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 2002, 30(7):783-791.
79. Tormin A., Li O., Brune J.C., Walsh S., Schutz B., Ehinger M., et al. CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 2011, 117(19):5067-5077.
80. Maijenburg M.W., Kleijer M., Vermeul K., Mul E.P., van Alphen F.P., van der Schoot C.E., et al. The composition of the mesenchymal stromal cell compartment in human bone marrow changes during development and aging. Haematologica 2012, 97(2):179-183.
81. Boxall S.A., Jones E. Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int 2012, 2012:975871.
82. Boneberg E.M., Illges H., Legler D.F., Furstenberger G. Soluble CD146 is generated by ectodomain shedding of membrane CD146 in a calcium-induced, matrix metalloprotease-dependent process. Microvasc Res 2009, 78(3):325-331.
83. Gomoll A.H., Madry H., Knutsen G., van Dijk N., Seil R., Brittberg M., et al. The subchondral bone in articular cartilage repair: current problems in the surgical management. Knee Surg Sports Traumatol Arthrosc 2010, 18(4):434-447.
84. Koga H., Muneta T., Ju Y.J., Nagase T., Nimura A., Mochizuki T., et al. Synovial stem cells are regionally specified according to local microenvironments after implantation for cartilage regeneration. Stem Cells 2007, 25(3):689-696.
85. Khan I.M., Gilbert S.J., Singhrao S.K., Duance V.C., Archer C.W. Cartilage integration: evaluation of the reasons for failure of integration during cartilage repair. Eur Cell Mater 2008, 16:26-39.
86. Bos P.K., De Groot J., Budde M., Verhaar J.A., van Osch G.J. Specific enzymatic treatment of bovine and human articular cartilage: implications for integrative cartilage repair. Arthritis Rheum 2002, 46(4):976-985.
87. Van de Breevaart B.J., In der Maur C.D., Bos P.K., Feenstra L., Verhaar J.A., Weinans H., et al. Improved cartilage integration and interfacial strength after enzymatic treatment in a cartilage transplantation model. Arthritis Res Ther 2004, 6(5):R469-R476.
88. Gilbert S.J., Singhrao S.K., Khan I.M., Gonzalez L.G., Thomson B.M., Burdon D., et al. Enhanced tissue integration during cartilage repair invitro can be achieved by inhibiting chondrocyte death at the wound edge. Tissue Eng Part A 2009, 15(7):1739-1749.
89. Silverman R.P., Bonasser L., Passaretti D., Randolph M.A., Yaremchuk M.J. Adhesion of tissue-engineered cartilate to native cartilage. Plast Reconstr Surg 2000, 105(4):1393-1398.
90. Pabbruwe M.B., Esfandiari E., Kafienah W., Tarlton J.F., Hollander A.P. Induction of cartilage integration by a chondrocyte/collagen-scaffold implant. Biomaterials 2009, 30(26):4277-4286.
91. Ter Huurne M., Schelbergen R., Blattes R., Blom A., de Munter W., Grevers L.C., et al. Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. Arthritis Rheum 2012, 64(11):3604-3613.
92. Augello A., Tasso R., Negrini S.M., Cancedda R., Pennesi G. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 2007, 56(4):1175-1186.
93. Lee C.H., Cook J.L., Mendelson A., Moioli E.K., Yao H., Mao J.J. Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet 2010, 376(9739):440-448.
94. Zhang W., Chen J., Tao J., Jiang Y., Hu C., Huang L., et al. The use of type 1 collagen scaffold containing stromal cell-derived factor-1 to create a matrix environment conducive to partial-thickness cartilage defects repair. Biomaterials 2013, 34(3):713-723.
95. Wei L., Kanbe K., Lee M., Wei X., Pei M., Sun X., et al. Stimulation of chondrocyte hypertrophy by chemokine stromal cell-derived factor 1 in the chondro-osseous junction during endochondral bone formation. Dev Biol 2010, 341(1):236-245.
96. Murata K., Kitaori T., Oishi S., Watanabe N., Yoshitomi H., Tanida S., et al. Stromal cell-derived factor 1 regulates the actin organization of chondrocytes and chondrocyte hypertrophy. PLoS One 2012, 7(5):e37163.
97. Johnson K., Zhu S., Tremblay M.S., Payette J.N., Wang J., Bouchez L.C., et al. Astem cell-based approach to cartilage repair. Science 2012, 336(6082):717-721.
98. Tasso R., Gaetani M., Molino E., Cattaneo A., Monticone M., Bachi A., et al. The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model. Biomaterials 2012, 33(7):2086-2096.
99. Eltawil N.M., De Bari C., Achan P., Pitzalis C., Dell'Accio F. Anovel invivo murine model of cartilage regeneration. Age and strain-dependent outcome after joint surface injury. Osteoarthritis Cartilage 2009, 17(6):695-704.
100. Koshino T., Wada S., Ara Y., Saito T. Regeneration of degenerated articular cartilage after high tibial valgus osteotomy for medial compartmental osteoarthritis of the knee. Knee 2003, 10(3):229-236.
101. Kurth T.B., Dell'Accio F., Crouch V., Augello A., Sharpe P.T., De Bari C. Functional mesenchymal stem cell niches in the adult knee joint synovium invivo. Arthritis Rheum 2011, 63(5):1289-1300.